Hill Emily Luisa — SEC insider filings

SEC reporting owner CIK 1778279. 28 insider filings on record with FilingPulse; latest filed 2026-11-18.

Transaction summary — filings shown

Covers all 28 filings on record, filed 2021-01-07 to 2026-11-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
PTC THERAPEUTICS, INC. (PTCT)CHIEF FINANCIAL OFFICER16—19 legs · 46,618 sh · $2,688,43214
Replimune Group, Inc. (REPL)Chief Financial Officer12—7 legs · 63,852 sh · $798,6089

Insider filings — Hill Emily Luisa

FiledFormIssuerReported transactionsSource
2026-11-184Replimune Group, Inc. (REPL)Sale (S): 14,709 @ $21.60EDGAR
2026-08-194Replimune Group, Inc. (REPL)Sale (S): 9,256 @ $14.28EDGAR
2026-08-124Replimune Group, Inc. (REPL)Sale (S): 11,448 @ $12.97EDGAR
2026-05-204Replimune Group, Inc. (REPL)Sale (S): 7,812 @ $5.08EDGAR
2026-04-074Replimune Group, Inc. (REPL)Grant/award (A): 50,000 @ $0 · Grant/award (A): 75,000 (derivative) @ $0EDGAR
2025-12-194Replimune Group, Inc. (REPL)Grant/award (A): 60,000 @ $0EDGAR
2025-08-194Replimune Group, Inc. (REPL)Sale (S): 9,154 @ $5.37EDGAR
2025-05-224Replimune Group, Inc. (REPL)Sale (S): 2,535 @ $8.05EDGAR
2025-04-034Replimune Group, Inc. (REPL)Grant/award (A): 45,000 @ $0 · Grant/award (A): 67,500 (derivative) @ $0EDGAR
2024-08-194Replimune Group, Inc. (REPL)Sale (S): 8,938 @ $10.18EDGAR
2024-04-034Replimune Group, Inc. (REPL)Grant/award (A): 26,665 @ $0 · Grant/award (A): 80,000 (derivative) @ $0EDGAR
2023-09-204Replimune Group, Inc. (REPL)Grant/award (A): 83,330 @ $0 · Grant/award (A): 125,000 (derivative) @ $0EDGAR
2023-03-294PTC THERAPEUTICS, INC. (PTCT)Sale (S): 7,363 @ $45EDGAR
2023-02-024PTC THERAPEUTICS, INC. (PTCT)Sale (S): 575 @ $45.63EDGAR
2023-01-264PTC THERAPEUTICS, INC. (PTCT)Sale (S): 223 @ $47.45EDGAR
2023-01-124PTC THERAPEUTICS, INC. (PTCT)Sale (S): 497 @ $42.93 · Sale (S): 418 @ $44.36EDGAR
2023-01-114PTC THERAPEUTICS, INC. (PTCT)Sale (S): 758 @ $41.66EDGAR
2023-01-094PTC THERAPEUTICS, INC. (PTCT)Grant/award (A): 19,500 @ $0 · Grant/award (A): 42,500 (derivative) @ $0EDGAR
2022-04-014PTC THERAPEUTICS, INC. (PTCT)Sale (S): 7,910 @ $37.78EDGAR
2022-02-034PTC THERAPEUTICS, INC. (PTCT)Sale (S): 553 @ $40.00EDGAR
2022-01-274PTC THERAPEUTICS, INC. (PTCT)Sale (S): 211 @ $39.31EDGAR
2022-01-114PTC THERAPEUTICS, INC. (PTCT)Sale (S): 800 @ $38.52 · Grant/award (A): 15,600 @ $0 · Grant/award (A): 58,500 (derivative) @ $0EDGAR
2022-01-064PTC THERAPEUTICS, INC. (PTCT)Sale (S): 173 @ $41.16EDGAR
2021-02-024PTC THERAPEUTICS, INC. (PTCT)Sale (S): 541 @ $56.96EDGAR
2021-01-274PTC THERAPEUTICS, INC. (PTCT)Sale (S): 275 @ $62.05EDGAR
2021-01-124PTC THERAPEUTICS, INC. (PTCT)Option exercise (M): 2,430 @ $30.86 · Sale (S): 2,430 @ $69.75 · Option exercise (M): 3,825 @ $11.23 · Sale (S): 3,825 @ $69.75 · Option exercise (M): 10,500 @ $18.01 · Sale (S): 10,500 @ $69.75 · +6 moreEDGAR
2021-01-084PTC THERAPEUTICS, INC. (PTCT)Grant/award (A): 10,800 @ $0 · Grant/award (A): 63,000 (derivative) @ $0EDGAR
2021-01-074PTC THERAPEUTICS, INC. (PTCT)Sale (S): 112 @ $62.37 · Sale (S): 176 @ $62.37EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-09-28 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1778279 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs